from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0597c/-

LFCtreatmentdescriptionclass of inhibitor

0.193

Amikacinug/mL Amikacintranslation

-0.124

Cap5-10ug/mL Capreomycintranslation

-0.459

Rox10-50 ug/mL Roxithromycintranslation

-0.043

SM2-5 ug/mL Streptomycintranslation

-0.192

Tet5-10 ug/mL Tetracyclinetranslation

0.478

Rif0.2-5ug/mL Rifampicintranscription

-0.001

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.089

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.529

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.317

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.861

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.627

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.728

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.555

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.348

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.696

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.305

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.161

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.746

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.176

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.379

KCN5-20 ug/mL Potassium cyaniderespiration

-0.325

NaN30.2-2 mM Sodium aziderespiration

0.383

Nigericin50 uM Nigericinrespiration

0.342

TRC10-150 ug/mL Triclosanrespiration

-0.418

TRZ10-25 ug/mL Thioridazinerespiration

-0.073

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.297

menadione6-10 ug/mL Menadionerespiration

0.166

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.253

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.037

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.083

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.801

NRP_1Non-replicating persistence stage 1dosRassociated

0.244

Amp0.2mg/mL AmpicillincellWall

0.420

Cephalexin20-100 ug/mL CephalexincellWall

0.039

Cerulenin0.32-5 ug/mL CerulenincellWall

0.399

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.011

EMB10-20 ug/mL EthambutolcellWall

0.358

Eta12-40 ug/mL EthionamidecellWall

0.522

INH0.2-0.4 ug/mL IsoniazidcellWall

0.217

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.704

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.614

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.098

BZA0.12 mg/mL BenzamidearomaticAmides

0.182

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.383

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.781

H2O24 mM hydrogen peroxideDNAdamaging

-0.170

Levo10 ug/mL LevofloxacinDNAdamaging

-0.541

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.759

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.236

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.501

UVUV-irradiationDNAdamaging

-0.069

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.590

Antimycin12.5-50 ug/mL Antimycin A?

0.729

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.508

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.717

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.320

PA8240.2-2 ug/mL PA-824?

1.440

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.478

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.223

Verapamil50 uM Verapamil?

0.687

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.148

methoxatin10-20 ug/mL Methoxatin?